• Home
  • To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States.

To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States.

Author List
Wang TS, Cheung K, Mehta P, Roman SA, Walker HD, Sosa JA
Publication
The Journal of clinical endocrinology and metabolism
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1474314
Publication Year
2010
PubMed ID
20139234
Publication Title
Wang TS, Cheung K, Mehta P, Roman SA, Walker HD, Sosa JA. To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States. J Clin Endocrinol Metab. 2010 Apr; 95(4):1672-80.